|
|||||
|
|
| 脑心通胶囊治疗中风恢复期气虚血瘀证的临床研究 | |
| 引用本文： | 苏莉雅,李应昆,吕斌,吉海旺,丁红,胡铃香,方素钦,梁晖,曹小菊,王忠.脑心通胶囊治疗中风恢复期气虚血瘀证的临床研究[J].中国中药杂志,2011,36(11):1530-1533. |
| 作者姓名： | 苏莉雅 李应昆 吕斌 吉海旺 丁红 胡铃香 方素钦 梁晖 曹小菊 王忠 |
| 作者单位： | 1. 中国中医科学院,北京,100700 2. 成都中医药大学附属医院,四川成都,610072 3. 陕西省人民医院,陕西西安,710068 4. 福建省中医药研究院,福建福州,350003 |
| 摘 要： | 目的:研究脑心通胶囊治疗中风病恢复期气虚血瘀证(脑梗塞)的有效性和安全性,并与阳性药通心络胶囊作非劣分析.方法:以通心络胶囊为对照,进行随机、双盲、对照、多中心临床试验.评价指标有中风病积分值的减少,中医证候的变化,患者生活能力状态(病残程度)的改善,中国脑卒中量表(CSS),日常生活活动(DAL)量表及Barthel指数(BI)记分.结果:两组总疗效、中医症候等比较均无显著的统计学意义.结论:脑心通胶囊对中风恢复期,气虚血瘀证(脑梗塞)具有治疗作用,且较为安全. |
| 关 键 词： | 脑心通 中风 脑梗塞 气虚血瘀证 疗效 非劣效性 |
| 收稿时间： | 2010/11/30 0:00:00 |
Clinical study on Naoxintong capsule for stroke recovery of Qi-deficiency and blood-stasis syndrome |
|
| SU Liy,LI Yingkun,LV Bin,JI Haiwang,DING Hong,HU Lingxiang,FANG Suqin,LIANG Hui,CAO Xiaoju and WANG Zhong.Clinical study on Naoxintong capsule for stroke recovery of Qi-deficiency and blood-stasis syndrome[J].China Journal of Chinese Materia Medica,2011,36(11):1530-1533. | |
| Authors: | SU Liy LI Yingkun LV Bin JI Haiwang DING Hong HU Lingxiang FANG Suqin LIANG Hui CAO Xiaoju and WANG Zhong |
| Institution: | China Academy of Chinese Medial Sciences, Beijing 100700, China;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China;Shaanxi Provincial People's Hospital, Xi'an 710068, China;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China;Affiliated Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China;Fujian Institute of Chinese Medicine, Fuzhou 350003, China;Fujian Institute of Chinese Medicine, Fuzhou 350003, China;Shaanxi Provincial People's Hospital, Xi'an 710068, China;China Academy of Chinese Medial Sciences, Beijing 100700, China |
| Abstract: | Objective : To study the efficacy and safety of Naoxintong capsule treatment of stroke recovery with Qi-deficiency and blood-stasis syndrome (cerebral infarction), and to compared the non-inferiority analysis with the positive drug Tongxinluo capsule. Method : Taking Tongxinluo capsules as control, randomized, double-blind, controlled, multi-center clinical experiments were studied. The evaluating indexes included the decrease of integral value of stroke patients, changes in traditional Chinese medicine, the improvement of the patient viability status (disability level), Chinese stroke scale (CSS), activities of daily living (DAL) scale and barthel index (BI ) points. Result : The total effect of the two groups, Chinese and other symptoms, showed no significant statistical significance. Conclusion : Naoxintong capsule stroke recovery, with Qi-deficiency and blood-stasis syndrome (cerebral infarction) has a therapeutic effect, and more secure. |
| Keywords: | Naoxintong capsule stroke cerebral infarction Qi-deficiency and blood-stasis syndrome effect non-inferiority efficacy |
| 本文献已被 CNKI 万方数据 PubMed 等数据库收录！ | |